SINGAPORE, July 31, 2013 /PRNewswire/ - Zecotek Photonics Inc. (TSX-V: ZMS; OTCPK: ZMSPF; Frankfurt: W1I), a developer of leading-edge photonics technologies for medical,
industrial and scientific markets, today announced that it has received
a $500,000 order for its patented Lutetium Fine Silicate (LFS)
scintillation crystals from its strategic partner Hamamatsu Photonics
(Tokyo: 6965) of Japan. The initial batch of LFS scintillation
crystals will be used in third party positron emission tomography (PET)
medical scanning devices.
"Hamamatsu has made an immediate contribution to our strategic
alliance," said Dr. A.F. Zerrouk, Chairman, President, and CEO of
Zecotek Photonics Inc. "This initial order underlines the significance
of the strategic partnership and cooperation between Zecotek and
Hamamatsu. We have always believed in the cost/performance superiority
of Zecotek LFS crystals. It has, however, been a challenge penetrating
the large-scale imaging markets. Hamamatsu's partnership removes
barriers and opens imaging industry opportunities for Zecotek
products. We look forward to growing the partnership as we move ahead
to capture a substantial share of the imaging markets."
On July 16, 2013 Zecotek and Hamamatsu announced a strategic partnership
to commercialize existing imaging technologies and to collaborate on
the upgrade and manufacture of photo detectors, integrated detector
modules and associated electronics and data acquisition modules for the
imaging markets at large. Hamamatsu is the world's leading supplier of
optoelectronics components including photo multiplier tubes and
photo-diodes used in positron emission tomography (PET) medical
scanners, the European Organization for Nuclear Research (CERN)
projects and other industrial and scientific applications.
Zecotek's patented (US patent No. 7,132,060) LFS series of scintillation
crystals are known for their high light yields and ultra-fast decay
times which allow for faster and higher-resolution operation of medical
and industrial imaging devices including PET medical scanners.
Zecotek's line of LFS crystals also cover a wide range of emission
wavelengths which can be tailored to match the spectral sensitivity of
various photo detectors including the solid-state MAPD photo detector
The LFS scintillation crystals will be supplied by the Beijing
Opto-Electronics Technology Company (BOET), a subsidiary of North-China
Research Institute of Electronics-Optics an industry leader in growing,
cutting, polishing and large scale production of scintillation crystals
grown by the Czochralski method. Zecotek's manufacturing process
permits the growth of very large-diameter boules with uniform
properties and without cracking (a problem with many competing
scintillation materials), resulting in high element output and lower
About Hamamatsu Photonics K.K.
Hamamatsu Photonics K.K. (Japan) is a leading manufacturer of devices
for the generation and measurement of infrared, visible, and
ultraviolet light. These devices include photomultiplier tubes,
scientific light sources, opto-semiconductors, cameras, and specialized
imaging systems. Hamamatsu Photonics is dedicated to the advancement of
photonics through extensive research. This corporate philosophy results
in state-of-the-art products which are used throughout the world in
scientific, industrial, and commercial applications.
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics
technology company developing high-performance scintillation crystals,
photo detectors, positron emission tomography scanning technologies, 3D
auto-stereoscopic displays, and lasers for applications in medical,
high-tech and industrial sectors. Founded in 2004, Zecotek
operates three divisions: Imaging Systems, Laser Systems and 3D Display
Systems with labs located in Canada, Korea, Russia, Singapore and
U.S.A. The management team is focused on building shareholder value by
commercializing over 50 patented and patent pending novel photonic
technologies directly and through strategic alliances and joint
ventures with leading industry partners such as the European
Organization for Nuclear Research (Switzerland), Beijing
Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems
(South Korea), and National NanoFab Center (South Korea). For more
information visit www.zecotek.com, follow @zecotek on Twitter and "like" us in Facebook at www.facebook.com/zecotek.
This press release may contain forward-looking statements that are based
on management's expectations, estimates, projections and assumptions.
These statements are not guarantees of future performance and involve
certain risks and uncertainties, which are difficult to predict.
Therefore, actual future results and trends may differ materially from
what may have been stated.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of the content of
this news release. If you would like to receive news from Zecotek in
the future please visit the corporate website at www.zecotek.com.
SOURCE Zecotek Photonics Inc.